Multilateral development banks (MDBs) are moving to centre stage in global health financing, driven by collapsing bilateral aid and political momentum from initiatives like the Accra Reset. Experts view the shift as an opportunity to deliver the predictable, large-scale investment needed to strengthen domestic health systems – provided governments and lenders can ensure transparent terms […] Continue reading ->
WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence  “within three to four weeks” – as soon as  DRC regulators issue their own approval,  said WHO’s Science Director Meg Doherty, at a Wednesday […] Continue reading ->
Hanan Balkhy, Saudi Arabia’s candidate for WHO Director General, is especially concerned about antibiotic resistance, the effects of climate change on health, and healthcare in conflict zones. She also warns about a “normalisation” of attacks on hospitals and healthcare workers in conflict regions. As a longtime WHO insider, she is also well aware that the […] Continue reading ->
While substantial progress has been made in driving down the global burden of neglected tropical diseases (NTDs), trends are  “uneven and fragile”, and several diseases are off course to meet 2030 targets. This is according to the World Health Organization (WHO)’s Global Report on Neglected Tropical Diseases 2026, a mid-term evaluation of the 2021-2030 road […] Continue reading ->
France’s Ambassador for Global Health, Dr Anne-Claire Amprou, is joining the leadership of the World Health Organization (WHO) body negotiating the missing piece of the Pandemic Agreement at a crucial moment. Amprou co-chaired the last stage of Pandemic Agreement talks, which eventually found consensus. However, consensus has eluded WHO member states on the pathogen access […] Continue reading ->